Page 21 - Bridge Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(2) Be The Match BioTherapies will provide streamlined supply chain services in support of Orchard's commercial-stage gene therapy in Europe Be The Match BioTherapies, an organization offering solutions for companies developing and commercializing cell and gene therapies, today announced an expansion of their multi-year partnership with Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, to include supply chain services in support of the upcoming commercial launch of Libmeldy (autologous CD34+ cells encoding the ARSA gene), Orchard's gene therapy recently approved in Europ...

Aurinia Pharmaceuticals Inc.: Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan - Agreement includes royalties of up to 20 percent on net sales payable to Aurinia - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH TSX:AUP) ("Aurinia" or the "Company") today announced it has entered into a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. for the development and commercialization of oral voclosporin for the treatment of Lupus Nephritis (LN) in the European Un...

New today, the president lashing out on twitter against a growing number of investigations and calling his previous attorney michael cohen a rat. but cohen is not the only one cooperating with prosecution into investigation of women paid by president trump. joining me now, stu aiken, the former executive of the company national inquirer now a member of bridge communications. steve, i want to be clear that you were not at a mirmi during 2016 election, but i want to start with how things work in the tabloid world, and how speaking with prosecutors could be a problem for the president. >> thanks,...